DPD (DIHYDROPYRIMIDINE DEHYDROGENASE) GENE DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited 

The DPD (Dihydropyrimidine Dehydrogenase) Gene Detection / EDTA Blood test identifies mutations in the DPD gene that affect the metabolism of fluoropyrimidine drugs like 5-fluorouracil (5-FU). Metropolis Healthcare uses advanced molecular techniques to provide precise and clinically actionable results. This test helps clinicians predict drug toxicity, guide safe chemotherapy dosing, and optimize treatment plans. An EDTA blood sample ensures high-quality DNA for accurate genetic analysis.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 7,500.00

Sample Type: EDTA BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the DPD Gene Detection test include?
This test screens for mutations in the DPD gene that may impair enzyme function and affect fluoropyrimidine drug metabolism.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques such as PCR and sequencing to detect DPD gene mutations accurately.

Who should take this test?
Patients scheduled for chemotherapy with fluoropyrimidines, or those with prior severe drug reactions, may be advised to undergo this test.

What sample type is required?
An EDTA anticoagulated blood sample is required for high-quality DNA extraction and precise genetic analysis.

Why is detecting DPD mutations important?
DPD gene mutations can lead to severe toxicity from fluoropyrimidine chemotherapy; identifying them allows safe dosing and personalized treatment planning.

How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated molecular protocols, and expert interpretation to ensure accurate and reproducible results.

Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.

How soon are results available?
Turnaround time may vary depending on the analysis method, but Metropolis Healthcare provides timely and comprehensive reports to guide clinical decisions.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab